Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Tob Control ; 13 Suppl 1: i20-9, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14985613

ABSTRACT

OBJECTIVE: To examine an industry funded and controlled study of in flight air quality (IFAQ). METHODS: Systematic search of internal tobacco industry documents available on the internet and at the British American Tobacco Guildford Depository. RESULTS: Individuals from several tobacco industry companies, led by Philip Morris, designed, funded, conducted, and controlled the presentation of results of a study of IFAQ for the Scandinavian airline SAS in 1988 while attempting to minimise the appearance of industry control. Industry lawyers and scientists deleted results unfavourable to the industry's position from the study before delivering it to the airline. The published version of the study further downplayed the results, particularly with regard to respirable suspended particulates. The study ignored the health implications of the results and instead promoted the industry position that ventilation could solve problems posed by secondhand smoke. CONCLUSIONS: Sponsoring IFAQ studies was one of several tactics the tobacco industry employed in attempts to reverse or delay implementation of in-flight smoking restrictions. As a result, airline patrons and employees, particularly flight attendants, continued to be exposed to pollution from secondhand smoke, especially particulates, which the industry's own consultants had noted exceeded international standards. This case adds to the growing body of evidence that scientific studies associated with the tobacco industry cannot be taken at face value.


Subject(s)
Aerospace Medicine , Aircraft , Occupational Exposure/adverse effects , Tobacco Industry , Tobacco Smoke Pollution/adverse effects , Air Pollutants/analysis , Attitude to Health , Carbon Dioxide/analysis , Carbon Monoxide/analysis , Conflict of Interest , Humans , Nicotine/analysis , Occupational Exposure/analysis , Occupational Exposure/prevention & control , Research Support as Topic , Smoke/adverse effects , Sweden , Tobacco Smoke Pollution/analysis , Tobacco Smoke Pollution/prevention & control , Ventilation
2.
J Econ Entomol ; 94(3): 658-65, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11425020

ABSTRACT

The feasibility of disrupting mating of Sparganothis fruitworm with a sprayable microencapsulated formulation of (E)-11-tetradecenyl acetate (E11-14:Ac), the major pheromone component, was evaluated in New Jersey during 1996 and 1997 seasons. In both years, application of encapsulated E11-14:Ac, at 25-187.5 g (AI)/ha, reduced the incidence of mating of virgin females placed in treated plots relative to those placed in control plots. Pheromone trap catches were lower in pheromone treated plots, indicating that fewer male moths were able to locate the traps in treated plots. Larval density and fruit damage were significantly lower in plots treated with 62.5,125, or 187.5 g (AI)/ha of pheromone than in the untreated control. Air and foliage samples were collected to determine the air titers and foliage residuals of E11-14:Ac throughout the adult flight during 1996 and 1997. E11-14:Ac levels in air and foliage samples, declined sharply one wk after the pheromone application. However, detectable levels of E11-14:Ac were present in both air and foliage samples throughout the 3- to 4-wk period after the pheromone application. Multiple applications of pheromone at lower rates may be more effective in maintaining pheromone levels than a single dose at higher rates. These results suggest that mating disruption is a promising strategy to manage Sparganothis fruitworm in cranberries.


Subject(s)
Fatty Acids, Monounsaturated/pharmacology , Moths/drug effects , Pest Control, Biological/methods , Sex Attractants/pharmacology , Sexual Behavior, Animal/drug effects , Vaccinium macrocarpon , Animals , Female , Male , Moths/physiology
4.
Lancet ; 2(8045): 956-9, 1977 Nov 05.
Article in English | MEDLINE | ID: mdl-72292

ABSTRACT

Human and animal forms of African trypanosomiasis are characterised by sustained hypocomplementaemia, gross hypergammaglobulinaemia M, and profound immunosuppression. It is suggested that this hypocomplementaemia is probably due to the action of a trypanosome-derived complement-activating factor and that the elevated IgM levels may be the combined result of this decomplementation, together with a subsequent failure of the normal IgM-to-IgG antibody switch mechanism and polyclonal B-lymphocyte activation by a trypanosome-generated mitogen. The immunosuppression in this disease may be a result of the collective immunosuppressive effects of trypanosome-derived immune-modulating free fatty acids, polyclonally stimulating B-cell mitogen, and complement-activating factors.


Subject(s)
B-Lymphocytes/immunology , Complement System Proteins , Fatty Acids, Nonesterified/immunology , Immunosuppression Therapy , Trypanosomiasis, African/etiology , Trypanosomiasis, African/immunology , Animals , Clone Cells/immunology , Complement System Proteins/deficiency , Dysgammaglobulinemia/etiology , Humans , Hypergammaglobulinemia/etiology , Immunoglobulin A , Immunoglobulin E , Immunoglobulin M/biosynthesis , Immunologic Deficiency Syndromes , Lymphopenia/etiology , Trypanosoma brucei gambiense/immunology , Trypanosomiasis, African/parasitology , Trypanosomiasis, African/veterinary
5.
Immunology ; 28(1): 1-21, 1975 Jan.
Article in English | MEDLINE | ID: mdl-46839

ABSTRACT

The time course of the localization of a protein antigen human serum albumin (HSA) into the chicken spleen after intravenous injection is analysed. Localization within seconds to the region surrounding the Schweigger-Seidel sheaths is accomplished by HSA complexes with chicken anti-HSA or by heat aggregated HSA. The localization of soluble HSA has to await the synthesis of sufficient chicken anti-HSA to accomplish localization to the same white pulp sites in the spleen at 25-30 hours after injection. By the use of complexes of HSA-anti-HSA in ten times antigen excess, the time for localization of HSA withing germinal centres was accelerated as compared with soluble HSA, so that newly formed centres containing antigen-bearing dendritic ells were seen at 48 hours instead of 72 hours after use of soluble HSA. Neonatally bursectomized and irradiated (Bx+Irr.) birds fail to localize HSA into germinal centres or to dendritic cells within the white pulp. Heat-aggregated human gamma-globulin (HGG) injected intravenously into Bx+Irr. birds rapidly localizes within seconds to the periphery of Schweigger-Seidel sheaths and at 24 hours can be seen attached to the surface of typical dendritic cells throughout the white pulp. Hence, heat-aggregated HGG can localize to dendritic cells in the absence of specific antibody. However, such localization to dendritic cells in Bx+ Irr. birds is not followed by segregation of the aggregated HGG-bearing dendritic cells within germinal centres--a further stage in the process which is presumed to require B cells and/or specific antibody. Localization of heat-aggregated HGG to white pulp dendritic ells was prevented by treatment with pepsin sufficient to destroy the ability of aggregated HGG to activate guinea-pig complement. Similary, in vivo decomplementation with a purified anticomplementary fraction (CoF) from the venom of Naja naja resulted in failure of intravenously injected HSA to localize to white pulp dendritic cells and failure of subsequent germinal centre formation. However, such decomplementation did not prevent the localization of aggregated HGG to white pulp dendritic cells. These facts are discussed in the light of hypotheses concerning germinal centre formation and the homeostasis of the antibody response in the bird.


Subject(s)
Serum Albumin/immunology , Spleen/immunology , Animals , Antibody Formation , Antigen-Antibody Complex , Bursa of Fabricius/immunology , Chickens , Chromatography, Ion Exchange , Complement System Proteins/analysis , Cytotoxicity Tests, Immunologic , Dialysis , Electrophoresis , Homeostasis , Hot Temperature , Humans , Immunity/radiation effects , Immunosuppression Therapy , Injections, Intravenous , Male , Microscopy, Fluorescence , Morphogenesis , Pepsin A/pharmacology , Snake Venoms/pharmacology , Spleen/anatomy & histology , Spleen/cytology , Time Factors , Ultracentrifugation , gamma-Globulins
SELECTION OF CITATIONS
SEARCH DETAIL
...